A Study of AK129 in Patients With Advanced Malignant Tumors
NCT05645276
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
182
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Tumors(Stage IA-IB)
Interventions
DRUG:
AK129 IV infusion
Sponsor
Akeso